Skip to main content
. 2018 Nov 8;19(11):3521. doi: 10.3390/ijms19113521

Figure 1.

Figure 1

Selection of glycation agent. (a) Viability of normal human dermal fibroblasts (NHDF) and normal human keratinocytes (NHK) following exposure to ribose or glyoxal for 48 h. (b) Advanced glycation end-products (AGEs) in collagen following the exposure to 10 mM ribose or 10 mM glyoxal. n = 3, mean + SD.